Adolescent PCOS: a postpubertal central obesity syndrome
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Adolescent polycystic ovary syndrome (PCOS) is a highly prevalent, reversible, endocrine-metabolic mode essentially driven by ectopic fat, which, in turn, often results from a mismatch between early adipogenesis and later lipogenesis, or between prenatal and postnatal weight gain. The key features of adolescent PCOS are menstrual irregularity and androgen excess (hirsutism, acne, and/or high testosterone). Adolescent PCOS is frequently preceded by rapid maturation (early variants of adrenarche/pubarche and puberty/menarche, also accelerated by ectopic fat) and is diagnosed between 2 and 8 years after menarche, thus during late adolescence or early adulthood. Treatment of adolescent PCOS should not only focus on symptoms, but also reduce the amount of ectopic fat, thereby aiming for an overall state of preconception health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over
Ryan, D. H., & Yockey, S. R. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0262-y · Cited by 831
Once-weekly semaglutide in adolescents with obesity
Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., Kelly, A. S., Mastrandrea, L. D., Sørrig, R., & Arslanian, S. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208601 · Cited by 730
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916038 · Cited by 723
Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Azziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Self-citationYildiz, B. O., Bolour, S., Woods, K., Moore, A., & Azziz, R. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp024 · Cited by 395
Research works printed but not linked: 62
- Witchel, 2015, The diagnosis of polycystic ovary syndrome during adolescence, Horm. Res. Paediatr., 83, 376, 10.1159/000375530 · DOI · Paper page
- Farland, 2022, Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts, Hum. Reprod., 37, 2690, 10.1093/humrep/deac210 · DOI
- Ryu, 2021, Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort study, Fertil. Steril., 115, 1569, 10.1016/j.fertnstert.2020.12.018 · DOI
- Falzarano, 2022, Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 107, 258, 10.1210/clinem/dgab658 · DOI
- Karjula, 2020, Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms, J. Clin. Endocrinol. Metab., 105, 1814, 10.1210/clinem/dgz256 · DOI · Paper page
- de Zegher, 2009, Adipose tissue expandability and the early origins of PCOS, Trends Endocrinol. Metab., 20, 418, 10.1016/j.tem.2009.06.003 · DOI
- Elks, 2014, Associations between genetic obesity susceptibility and early postnatal fat and lean mass: an individual participant meta-analysis, JAMA Pediatr., 168, 1122, 10.1001/jamapediatrics.2014.1619 · DOI · Paper page
- de Zegher, 2019, Towards a simple marker of hepato-visceral adiposity and insulin resistance: the Z-score change from weight-at-birth to BMI-in–childhood, Pediatr. Obes., 14, 10.1111/ijpo.12533 · DOI
- Sebastiani, 2016, The sequence of prenatal growth restraint and postnatal catch-up growth leads to a thicker intima-media and more pre-peritoneal and hepatic fat by age 3-6 years, Pediatr. Obes., 11, 251, 10.1111/ijpo.12053 · DOI · Paper page
- Ibáñez, 2006, Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children, J. Clin. Endocrinol. Metab., 91, 2153, 10.1210/jc.2005-2778 · DOI · Paper page
- Ong, 2020, Mismatch between poor fetal growth and rapid postnatal weight gain in the first 2 years of life is associated with higher blood pressure and insulin resistance without increased adiposity in childhood: the GUSTO cohort study, Int. J. Epidemiol., 49, 1591, 10.1093/ije/dyaa143 · DOI
- Charkaluk, 2004, Premature pubarche as an indicator of how body weight influences the onset of adrenarche, Eur. J. Pediatr., 163, 89, 10.1007/s00431-003-1358-9 · DOI
- Ong, 2004, Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls, J. Clin. Endocrinol. Metab., 89, 2647, 10.1210/jc.2003-031848 · DOI · Paper page
- Neville, 2005, Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity, Arch. Dis. Child., 90, 258, 10.1136/adc.2004.053959 · DOI · Paper page
- Liimatta, 2018, Trajectories of growth and serum DHEAS and IGF-1 concentrations in girls with a history of premature adrenarche: attenuation of the phenotype by adulthood, Front. Endocrinol., 9, 375, 10.3389/fendo.2018.00375 · DOI
- Ibáñez, 1998, Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth, J. Clin. Endocrinol. Metab., 83, 3558, 10.1210/jcem.83.10.5205 · doi:10.1210/jcem.83.10.5205 · Paper page
- Harbulot, 2021, Prevalence and clinical characteristics of isolated forms of central precocious puberty: a cohort study at a single academic center, Eur. J. Endocrinol., 184, 243, 10.1530/EJE-20-0862 · DOI
- de Zegher, 2021, On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls, Eur. J. Endocrinol., 185, L1, 10.1530/EJE-21-0287 · DOI
- Kaltenbach, 2017, Thyroid dysfunction and hepatic steatosis in overweight children and adolescents, Pediatr. Obes., 12, 67, 10.1111/ijpo.12110 · DOI
- Kim, 2022, Obesity is associated with adolescent hyperandrogenemia in girls aged 6-18, National Health and Nutrition Examination Survey (NHANES) 2013–2016, J. Endocr. Soc., 6, A679, 10.1210/jendso/bvac150.1404 · doi:10.1210/jendso/bvac150.1404
- Su, 2020, Factors affecting bone maturation in Chinese girls aged 4–8 years with isolated premature thelarche, BMC Pediatr., 20, 356, 10.1186/s12887-020-02256-w · DOI
- Sánchez-Garrido, 2022, Early programming of reproductive health and fertility: novel neuroendocrine mechanisms and implications in reproductive medicine, Hum. Reprod. Update, 28, 346, 10.1093/humupd/dmac005 · DOI
- Argente, 2023, Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications, Lancet Diabetes Endocrinol, 11, 203, 10.1016/S2213-8587(22)00339-4 · DOI
- Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J. Clin. Endocrinol. Metab., 96, 3533, 10.1210/jc.2011-1609 · DOI · Paper page
- Legro, 2010, Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives, J. Clin. Endocrinol. Metab., 95, 789, 10.1210/jc.2009-1849 · DOI · Paper page
- Ünlütürk, 2016, Evolutionary determinants of polycystic ovary syndrome: part 1, Fertil. Steril., 106, 33, 10.1016/j.fertnstert.2016.05.010 · DOI
- Ibáñez, 1999, Anovulation after precocious pubarche: early markers and time course in adolescence, J. Clin. Endocrinol. Metab., 84, 2691
- Peña, 2020, Adolescent polycystic ovary syndrome according to the international, evidence-based guideline, BMC Med., 18, 72, 10.1186/s12916-020-01516-x · DOI · Paper page
- Peña, 2022, Criteria for diagnosis of polycystic ovary syndrome during adolescence: literature review, Diagnostics, 12, 1931, 10.3390/diagnostics12081931 · DOI
- van Hooff, 1999, Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents, Hum. Reprod., 14, 2223, 10.1093/humrep/14.9.2223 · DOI · Paper page
- Davis-Kankanamge, 2016, The association between body mass index and androgen levels in adolescent girls with irregular menses or amenorrhea, Fertil. Steril., 106, 10.1016/j.fertnstert.2016.07.735 · doi:10.1016/j.fertnstert.2016.07.735
- Ferriman, 1961, Clinical assessment of body hair in women, J. Clin. Endocrinol. Metab., 21, 1440, 10.1210/jcem-21-11-1440 · DOI · Paper page
- Gambineri, 2013, Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on Italian high-school students, J. Clin. Endocrinol. Metab., 98, 1641, 10.1210/jc.2012-3537 · DOI · Paper page
- Salameh, 2014, Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria, Fertil. Steril., 101, 1135, 10.1016/j.fertnstert.2013.12.056 · DOI · Paper page
- Lennon, 2022, Preconception health optimization in women with polycystic ovary syndrome - how to find the time?, Curr. Opin. Endocrinol. Diabetes Obes., 29, 541, 10.1097/MED.0000000000000781 · DOI
- Moore, 2021, Weight management in adolescents with polycystic ovary syndrome, Curr. Obes. Rep., 10, 311, 10.1007/s13679-021-00437-x · DOI
- Simon, 2020, Poor sleep is related to metabolic syndrome severity in adolescents with PCOS and obesity, J. Clin. Endocrinol. Metab., 105, 10.1210/clinem/dgz285 · DOI · Paper page
- Mena, 2019, The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis, Hum. Reprod. Update, 25, 541, 10.1093/humupd/dmz013 · DOI
- Rosqvist, 2019, Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial, J. Clin. Endocrinol. Metab., 104, 6207, 10.1210/jc.2019-00160 · DOI · Paper page
- Yu, 2022, Sleep duration and visceral adipose tissue: linear and nonlinear Mendelian randomization analyses, J. Clin. Endocrinol. Metab., 107, 2992, 10.1210/clinem/dgac551 · DOI
- Papaetis, 2022, GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: current research and future horizons, Adv. Clin. Exp. Med., 31, 1265, 10.17219/acem/151695 · DOI
- Kuo, 2022, HOTAIR interacts with PRC2 complex regulating the regional preadipocyte transcriptome and human fat distribution, Cell Rep., 40, 10.1016/j.celrep.2022.111136 · DOI
- Ibáñez, 2017, Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome, J. Adolesc. Health, 61, 446, 10.1016/j.jadohealth.2017.04.010 · DOI
- Ibáñez, 2020, Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome, J. Endocr. Soc., 4
- Shorakae, 2019, Brown adipose tissue thermogenesis in polycystic ovary syndrome, Clin. Endocrinol., 90, 425, 10.1111/cen.13913 · DOI · Paper page
- Thuzar, 2019, Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study, Diabetes Obes. Metab., 21, 509, 10.1111/dom.13539 · DOI
- García-Beltran, 2020, Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization, BMJ Open Diabetes Res. Care, 8, 10.1136/bmjdrc-2019-001035 · DOI
- Ibáñez, 2008, Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin, Clin. Endocrinol., 68, 317, 10.1111/j.1365-2265.2007.03137.x · DOI · Paper page
- Li, 2020, Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice, Proc. Natl. Acad. Sci. U. S. A., 117, 32584, 10.1073/pnas.1922169117 · DOI · Paper page
- LaMoia, 2021, Cellular and molecular mechanisms of metformin action, Endocr. Rev., 42, 77, 10.1210/endrev/bnaa023 · DOI · Paper page
- de Zegher, 2021, The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat, Sci. Rep., 11, 7018, 10.1038/s41598-021-86317-9 · DOI
- Coll, 2020, GDF15 mediates the effects of metformin on body weight and energy balance, Nature, 578, 444, 10.1038/s41586-019-1911-y · DOI · Paper page
- Kincaid, 2022, Metformin and GDF15: where are we now?, Nat. Rev. Endocrinol., 19, 6, 10.1038/s41574-022-00764-6 · DOI
- Díaz, 2020, Low circulating levels of miR-451a in girls with polycystic ovary syndrome: different effects of randomized treatments, J. Clin. Endocrinol. Metab., 105, 10.1210/clinem/dgz204 · DOI
- Garcia-Beltrán, 2021, Gut microbiota in adolescent girls with polycystic ovary syndrome: effects of randomized treatments, Pediatr. Obes., 16, 10.1111/ijpo.12734 · DOI
- García-Beltrán, 2023, Raised thyroid stimulating hormone in girls with polycystic ovary syndrome: effects of randomized interventions, Horm. Res. Paediatr., 10.1159/000529183 · DOI
- Guarnotta, 2021, Predictive factors of polycystic ovary syndrome in girls with precocious pubarche, Endocr. Connect., 10, 796, 10.1530/EC-21-0118 · DOI
- Ibáñez, 2006, Metformin treatment to prevent early puberty in girls with precocious pubarche, J. Clin. Endocrinol. Metab., 91, 2888, 10.1210/jc.2006-0336 · DOI · Paper page
- Ibáñez, 2006, Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty, J. Clin. Endocrinol. Metab., 91, 2068, 10.1210/jc.2005-2329 · DOI · Paper page
- Ibáñez, 2004, Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome, J. Pediatr., 144, 23, 10.1016/j.jpeds.2003.08.015 · DOI
- Bassols, 2023, Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol, Trials, 24, 56, 10.1186/s13063-022-07050-w · DOI
- Popovic, 2022, Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States, Front. Pediatr., 10, 10.3389/fped.2022.968485 · DOI
Cited by
Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023) · Nutrients · doi:10.3390/nu15163582 · Cited by 27
Zhuang, J., Wang, Y., Wang, S., Hu, R., & Wu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64849-0 · Cited by 23
Xing, N.-N., Ren, F., & Yang, H. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.9835 · Cited by 13
Shen, J.-Y., Xu, L., Ding, Y., & Wu, X.-Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i23.5468 · Cited by 7
Metadata
- Authors
- Ibáñez, L., & de Zegher, F.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 29
- Issue
- 5
- Pages
- 354-363
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W4353062899
- Cited by
- 97
- References
- 21
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- European Commission
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Horizon 2020 (899671)
- European Regional Development Fund (PERIS-SLT017/20/000228, PI15/01078)
- Horizon 2020 Framework Programme
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adolescent PCOS: a postpubertal central obesity syndrome. https://app.cochat.ai/papers/10.1016/j.molmed.2023.02.006
- The paper
- Ibáñez, L., & de Zegher, F. (2023). Adolescent PCOS: a postpubertal central obesity syndrome. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2023.02.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.